Osamu Shiono
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial.
Journal: JMIR research protocols
Published: May 09, 2018
Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan.
Journal: Cancer chemotherapy and pharmacology
Published: May 08, 2017
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: March 22, 2016
Actinomycosis arising from the nasal cavity, with rare fatal progression.
Journal: BMJ case reports
Published: February 11, 2016
Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy.
Journal: Head & neck
Published: January 12, 2016
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma.
Journal: Anticancer research
Published: December 06, 2015
Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.
Journal: International journal of clinical oncology
Published: November 04, 2015
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
Journal: International journal of clinical oncology
Published: August 16, 2015
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Journal: International journal of clinical oncology
Published: May 26, 2015
Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT).
Journal: PloS one
Published: October 24, 2014
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
Journal: Japanese journal of clinical oncology
Published: October 01, 2014
Last Updated: 09/26/2026